Astex Announces New Drug Discovery Collaboration With Boehringer Ingelheim

CAMBRIDGE, U.K., Aug. 31, 2005 (PRIMEZONE) --Astex:

 - Astex and Boehringer Ingelheim form a further strategic alliance
  -- The alliance will focus on discovery, development and
     commercialisation of novel drug candidates
  -- Boehringer Ingelheim will pay Astex an upfront fee, fund
     research, provide milestone payments and royalties on commercial
  -- Astex has drug discovery collaborations with Astellas Pharma,
     AstraZeneca, Berlex, Boehringer Ingelheim, Mitsubishi Pharma,
     Sanofi-Aventis and Schering AG.  

To view this release as a .pdf visit the following link: